You are here :

  1. Home
  2. Investors
  3. US investors
  4. U.S. investors and individual shareholders

Change language :

Français

Investors

U.S. investors and individual shareholders

  • To print this page, please use the File menu or press simultaneously ctrl + p keys.
  • Send this page

The sanofi-aventis Investor Relations team is committed to providing the investment community with timely, transparent information on the Group’s business, organization and performance. A dedicated team is available in the U.S. to answer the questions of U.S. investors and individual shareholders.

 

For general enquiries, please call the switchboard at the U.S. headquarters: +1 908 981 5000

U.S. Investor Relations

If you are a U.S. individual shareholder please contact:

Institutional investors should contact:

Address at the U.S. headquarters:

  • Sanofi-aventis
    Investor Relations
    55 Corporate Drive
    Bridgewater, NJ 08807

JPMorgan Chase Bank, N.A.

JPMorgan Chase Bank, N.A. sponsors and administers our American Depositary Receipts (ADR) program. You can contact their sanofi-aventis shareholder services at:

  • Toll-free number in the U.S.: (1) 877 272 9475 
  • For international callers: (1) 651 453 2128 
  • Email: jpmorgan.adr@wellsfargo.com

Addresses

  • Regular correspondence:
    JPMorgan Chase Bank, NA
    P.O. BOX 64504
    St. Paul, MN 55164-0504
  • Delivery of stock certificates:
    JPMorgan Chase Bank, NA
    161 N Concord Exchange
    South St. Paul, MN 55075
  • Overnight mail:
    JPMorgan Chase Bank, NA
    161 N Concord Exchange
    South St. Paul, MN 55075

Euronext Paris (SAN)

Quote: €44.48. Level change: -0.77%
Last update: July 30, 2010 10.45 AM (CET)

NYSE (SNY)

Quote: $29.28. Level change: -0.01%
Last update: July 29, 2010 04.12 PM (EST)

Subscriptions

 

Fact Sheet

Sanofi-aventis
at a glance

 

Focus on...

Shareholders' General Meeting

The general meeting was held on: 
May 17, 2010
at the Palais des Congrès in Paris
 
A recorded video webcast is available on our website.